FYCOMPA

Država: Indonezija

Jezik: indonezijski

Izvor: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Preuzimanje Svojstava lijeka (SPC)
22-12-2023

Aktivni sastojci:

PERAMPANEL

Dostupno od:

EISAI INDONESIA - Indonesia

INN (International ime):

PERAMPANEL

Doziranje:

4 MG

Farmaceutski oblik:

TABLET SALUT SELAPUT

Jedinice u paketu:

DUS, 2 BLISTER @ 14 TABLET

Proizveden od:

EISAI INDONESIA - Indonesia

Datum autorizacije:

2019-09-06

Svojstava lijeka

                                PT Eisai Indonesia | Product Information FYCOMPA
1
1.
NAME OF THE MEDICINAL PRODUCT
Fycompa 2 mg, 4 mg, 8 mg film-coated tablets
2.
QUANTITATIVE COMPOSITION
Each film-coated tablet contains 2, 4, or 8 mg perampanel.
The complete quantitative composition can be found in Section 6.
3.
PHARMACEUTICAL FORM
Film-coated tablet
(tablet):
*)
2 mg tablet: Orange, round, biconvex tablet, debossed with Є275 on
one side and '2'
on the other side
*)
4 mg tablet: Red, round, biconvex tablet, debossed with Є277 on one
side and '4'
on
the other side
*) 8 mg tablet: Purple, round, biconvex tablet, debossed with Є295 on
one side and '8' on
the other side
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Fycompa must
be titrated,
according to individual
patient
response,
in order
to
optimise the balance between efficacy and tolerability.
Perampanel should be taken orally once daily at bedtime.
Treatment with Fycompa should be initiated with a dose of 2 mg/day.
The dose may
be increased based on individual clinical response and tolerability to
a maintenance
dose of 4 mg/day to 8 mg/day and if necessary up to 12 mg/day.
Adult / Adolescent (12 years of age and older) and
Children (4-11 years), weighing 30 kg or more
Recommended starting
2 mg/day
dose
Titration (incremental
2 mg/day
steps)
(no more frequently than weekly intervals)
Fycompa is indicated for the adjunctive treatment of partial-onset
seizures (POS) with
Fycompa is indicated for the adjunctive treatment of primary
generalised tonic-
clonic
seizures (PGTC) i
n patients from 7 years of age and older weighing 30 kg or more
with idiopathic generalised epilepsy (IGE).
_Partial-Onset Seizures: 4 years of age and older, weighing 30 kg or
more_
DISETUJUI OLEH BPOM: 22/12/2023
ID: EREG17180812200009
EREG17180812200010
EREG17180812200011
PT Eisai Indonesia | Product Information FYCOMPA
2
Recommended
4 – 8 mg/day
maintenance dose
Titration (incremental
2 mg/day
steps)
(no more frequently than weekly intervals)
Recommended maxi
                                
                                Pročitajte cijeli dokument
                                
                            

Upozorenja za pretraživanje vezana za ovaj proizvod

Pogledajte povijest dokumenata